Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF- 1 in patients with distinct types of primary glomerulonephritis
Author(s) -
Brigitte Bauvois,
Nadya Mothu,
JeanPaul Nguyen,
Thao NguyenKhoa,
LaureHélène Noël,
Paul Jungers
Publication year - 2007
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfl743
Subject(s) - matrix metalloproteinase , medicine , glomerulonephritis , metalloproteinase , transforming growth factor , fibrosis , extracellular matrix , kidney disease , immunology , matrix (chemical analysis) , pathology , kidney , microbiology and biotechnology , biology , materials science , composite material
Dysregulated renal expression of matrix metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMP) and TGF-beta1 contribute to the development of tubulo-interstitial fibrosis characteristic of progressive forms of primary glomerulonephritis (GN). There is little information on the circulating levels of these proteins in human GNs. Here, we assessed whether different histopathological GN types could be associated with distinct plasma patterns of MMPs and regulatory proteins.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom